Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma

Predictive biomarkers of the response of hepatocellular carcinoma (HCC) to Lenvatinib therapy have not yet been clarified. The aim of this study was to identify clinically significant biomarkers of response to Lenvatinib therapy, to target strategies against HCC. Levels of circulating angiogenic fac...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cancers (Basel)
Κύριοι συγγραφείς: Chuma, Makoto, Uojima, Haruki, Numata, Kazushi, Hidaka, Hisashi, Toyoda, Hidenori, Hiraoka, Atsushi, Tada, Toshifumi, Hirose, Shunji, Atsukawa, Masanori, Itokawa, Norio, Arai, Taeang, Kako, Makoto, Nakazawa, Takahide, Wada, Naohisa, Iwasaki, Shuitirou, Miura, Yuki, Hishiki, Satoshi, Nishigori, Shuhei, Morimoto, Manabu, Hattori, Nobuhiro, Ogushi, Katsuaki, Nozaki, Akito, Fukuda, Hiroyuki, Kagawa, Tatehiro, Michitaka, Kojiro, Kumada, Takashi, Maeda, Shin
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: MDPI 2020
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7073176/
https://ncbi.nlm.nih.gov/pubmed/31991869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020293
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια